DSS ▼ -3.9% - DSS, Inc. $DSS - DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited DSS, Inc. shares declined 3.9% following the company's announcement of a Form F-4 filing related to Impact Biomedical's proposed business combination with Zoar Limited. The filing indicates progress toward completing the merger transaction, though investors may be reacting to dilution concerns or other terms disclosed in the regulatory document. 16-SEP-2026 09:25 AM ET